Healius Ltd (ASX: HLS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Healius Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Healius Ltd (ASX: HLS)
Latest News
⏸️ Investing
ALL ORDINARIES finishes lower Friday: 8 shares you missed
⏸️ Investing
Why these 4 ASX shares are ending the week with a bang
⏸️ Investing
Why the Primary Health Care Limited share price climbed 5% on strong results
⏸️ Investing
7 shares you need to watch on Friday
⏸️ Investing
Why WAM Capital Limited owns shares of Primary Health Care Limited
⏸️ Investing
Top brokers name 3 ASX shares to sell
⏸️ Investing
What you need to watch on the ASX this week
⏸️ Investing
Why these healthcare shares could be good medicine for your portfolio
⏸️ Investing
UBS names its winners and losers of next month's earnings season
⏸️ Investing
Citigroup: CSL Limited & ResMed Inc. (CHESS) could soar this earnings season
⏸️ Investing
This healthcare stock is set for a nice earnings upgrade in 2018
⏸️ Investing
Have the share prices of Virtus Health Ltd and Monash IVF Group Ltd found a bottom?
Frequently Asked Questions
-
Yes, Healius has historically paid two fully franked shareholder dividends a year.
-
Healius has generally paid its shareholder dividends in March/April and September/October.
-
Healius Ltd listed on the ASX on 3 July 1998.
HLS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Healius Ltd
Healius Ltd (ASX: HLS) operates a network of pathology laboratories, diagnostic imaging centres, and day hospitals across Australia.
The company is Australia's second-largest pathology provider with around 2,000 collection sites and almost 100 pathology laboratories operating under a portfolio of brand names. The company says one in three pathology samples taken in Australia is tested in a Healius laboratory. It also operates around 150 imaging centres in public and private hospitals, medical centres, and community centres.
The company has identified its short-stay and day hospitals as a growth segment. It currently operates 15 day hospitals as well as four major IVF clinics.
